Why MCAS, POTS, and Ehlers-Danlos Often Occur Together
Why It Matters
Identifying the MCAS‑POTS‑hEDS triad enables earlier, coordinated interventions, reducing chronic symptom burden and health‑care costs for a population often misdiagnosed.
Key Takeaways
- •MCAS, POTS, and hypermobile EDS frequently co-occur as a triad
- •Mast cell activation drives gastrointestinal dysmotility and vascular compression
- •POTS symptoms stem from autonomic dysfunction linked to connective tissue laxity
- •Ehlers‑Danlos hypermobility causes joint laxity, organ prolapse, and gut issues
- •Early identification of the triad guides multidisciplinary treatment and symptom relief
Summary
The video spotlights the “evil triad” – mast cell activation syndrome (MCAS), postural orthostatic tachycardia syndrome (POTS) and hypermobile Ehlers‑Danlos syndrome (hEDS) – a cluster that often eludes standard diagnosis.
It explains how MCAS triggers systemic inflammation that impairs gut motility, leading to severe nausea, refractory SIBO, constipation and even vascular compression disorders such as median arcuate ligament syndrome and nutcracker syndrome. POTS adds autonomic instability, causing tachycardia on standing, while hEDS contributes connective‑tissue laxity that destabilizes joints and organ support, amplifying gastrointestinal and vascular symptoms.
The presenter calls the combination an “evil triad,” noting that patients may present with “loopy droopy” small‑intestine effects, chronic abdominal pain, and unexplained vascular syndromes. He cites median arcuate ligament syndrome, nutcracker syndrome, and refractory SIBO as hallmark examples that illustrate the triad’s systemic reach.
Recognizing this overlap encourages clinicians to order targeted mast‑cell panels, autonomic testing, and genetic connective‑tissue assessments, fostering a coordinated, multidisciplinary treatment plan that can dramatically improve quality of life for affected patients.
Comments
Want to join the conversation?
Loading comments...